HGH Fragment 176-191

Description

HGH Fragment 176-191

HGH Fragment 176-191 is a specialized fat-metabolism peptide derived from the active lipolytic region of Human Growth Hormone (HGH). Designed to support fat breakdown, metabolic activity, and body recomposition without the muscle-growth or IGF-1 stimulation effects of full HGH, it has become popular in advanced fat-loss and wellness protocols. HGH Frag 176-191 is widely researched for targeting stubborn fat while maintaining a more selective metabolic action profile.

Also known as: Frag 176-191, HGH Frag, AOD-9401

A fragment of human growth hormone known for its fat-metabolizing properties. This version includes only the component responsible for fat burning, avoiding impacts on blood glucose levels or cell growth.
•Status: Still under investigation—research is active. Evidence level: Studies conducted in humans.
•Common dosage: 250–500 mcg per day, divided into one or two injections, typically administered subcutaneously while fasting.
•Primary research focus: Reducing body fat, improving body composition, and targeting abdominal fat.